Clobenpropit: Difference between revisions

From Wikipedia, the free encyclopedia
Content deleted Content added
added chembl id
BogBot (talk | contribs)
populated new fields in {{drugbox}} and reordered per bot approval. Report errors and suggestions to User_talk:BogBot
Line 1: Line 1:
{{Drugbox
{{Drugbox
| IUPAC_name = ''N'''-[(4-chlorophenyl)methyl]-1-[3-(3''H''-imidazol-4-yl)propylsulfanyl]formamidine
| IUPAC_name = ''N'''-[(4-chlorophenyl)methyl]-1-[3-(3''H''-imidazol-4-yl)propylsulfanyl]formamidine
| image = Clobenpropit.svg
| image = Clobenpropit.svg

| CAS_number = 145231-45-4
<!--Clinical data-->
| ATC_prefix = none
| tradename =
| ATC_suffix =
| pregnancy_category =
| PubChem = 2790
| legal_status =
| routes_of_administration =

<!--Pharmacokinetic data-->
| bioavailability =
| metabolism =
| elimination_half-life =
| excretion =

<!--Identifiers-->
| CAS_number = 145231-45-4
| ATC_prefix = none
| ATC_suffix =
| PubChem = 2790
| IUPHAR_ligand = 1223
| IUPHAR_ligand = 1223
| ChemSpiderID = 2688
| ChemSpiderID = 2688
| ChEMBL = 14690
| ChEMBL = 14690

| C = 14 | H = 17 | Cl = 1 | N = 4 | S = 1
<!--Chemical data-->
| molecular_weight = 308.83 g/mol
| C=14 | H=17 | Cl=1 | N=4 | S=1
| smiles = C1=CC(=CC=C1CN=C(N)SCCCC2=CN=CN2)Cl
| molecular_weight = 308.83 g/mol
| bioavailability =
| smiles = C1=CC(=CC=C1CN=C(N)SCCCC2=CN=CN2)Cl
| metabolism =
| elimination_half-life =
| excretion =
| pregnancy_category =
| legal_status =
| routes_of_administration =
}}
}}



Revision as of 05:39, 2 September 2011

Clobenpropit
Clinical data
ATC code
  • none
Identifiers
  • N'-[(4-chlorophenyl)methyl]-1-[3-(3H-imidazol-4-yl)propylsulfanyl]formamidine
CAS Number
PubChem CID
IUPHAR/BPS
ChemSpider
ChEMBL
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC14H17ClN4S
Molar mass308.83 g/mol g·mol−1
3D model (JSmol)
  • C1=CC(=CC=C1CN=C(N)SCCCC2=CN=CN2)Cl

Clobenpropit is a histamine H3 receptor antagonist.[1] It has neuroprotective effects via stimulation of GABA release in the brain.[2]

See also

References

  1. ^ Sahlholm K, Nilsson J, Marcellino D, Fuxe K, Arhem P (2007). "The human histamine H3 receptor couples to GIRK channels in Xenopus oocytes". Eur. J. Pharmacol. 567 (3): 206–10. doi:10.1016/j.ejphar.2007.04.032. PMID 17537431.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  2. ^ Dai H, Fu Q, Shen Y, Hu W, Zhang Z, Timmerman H, Leurs R, Chen Z. The histamine H3 receptor antagonist clobenpropit enhances GABA release to protect against NMDA-induced excitotoxicity through the cAMP/protein kinase A pathway in cultured cortical neurons. European Journal of Pharmacology. 2007 Jun 1;563(1-3):117-23. PMID 17350613